I-Mab (NASDAQ: IMAB) is a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer. I-Mab has established operations in the U.S.

Broadleaf Partners Growth Equity Portfolio returned -11.6% for Q1 2025 vs. the S&P 500 -4.3% return. Click here to read the ...

Barfresh Food Group, Inc. (NASDAQ: BRFH) Q4 2024 Earnings Call Transcript March 27, 2025 Barfresh Food Group, Inc. misses on earnings expectations. Reported EPS is $-0.06 EPS, expectations were $-0.01 ...

Operator: Greetings, and welcome to the DURECT Corporation Fourth Quarter and Full Year 2024 Earnings Conference Call. At ...

China has released all Mintz employees who had been held in detention for two years since a raid on its Beijing office in March 2023, a spokesperson from the US-based due diligence firm Mintz ...

Just under half of U.S. employees who participated in a Gallup survey “strongly agreed” that they know what is expected of them at work.

HL Building Blocks Build your own portfolio with HL's specially designed fund range Wealth Shortlist A selection of funds we've researched and chosen for their long-term potential ...

The pandemic has left many workers unclear about job expectations ... Managers and employees have bushwhacked their way through disruptive changes since COVID-19 first upended public life five ...

Revenue expectations were also revised, now projected to be flat or slightly down year-over-year, compared to prior guidance of approximately flat. The results reflect ongoing freight market ...

FedEx (FDX) reported quarterly earnings that missed analysts’ expectations and cut its full-year outlook, sending shares lower in extended trading Thursday. The shipping giant said it expects ...